WASHINGTON, Nov. 8, 2013 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Jeff Huth, Senior Vice President, Managed Markets, Boehringer Ingelheim Pharmaceuticals Inc. (BI), has been elected chairman of its Board of Directors for 2013-14. Mr. Huth has served on NPC's Board since 2009 and has previously held the positions of vice chair and treasurer.
"Throughout his tenure on our board, Jeff has been dedicated to promoting NPC and its role as a leading health care policy research organization," said NPC President Dan Leonard. "We're looking forward to having Jeff play an even more active role in leading NPC's efforts on issues related to balancing the needs of patients with the population, the value of pharmaceuticals, and the use of real-world evidence."
Mr. Huth has more than 30 years of experience in the pharmaceutical industry, where he has served in a wide spectrum of roles ranging from pre-clinical development to marketing and sales management. His career with Boehringer Ingelheim has included international assignments at BI's affiliate in the United Kingdom and at corporate headquarters in Germany. Upon returning to the U.S., he assumed responsibility for marketing and in 2009 moved to his current position, for which he is responsible for pricing and contracting, trade relations, health economics and leading field-based teams interacting with customers in the private and government payer channels. In the U.S., BI develops and markets therapies in the respiratory, cardiovascular, metabolic, anti-viral and oncology areas.
The NPC Board also elected Anne Whitaker, President, North America Pharmaceuticals, Sanofi, as Vice Chair; David Martin, Vice President, Managed Markets, Value & Access Group, Eisai Inc. as Treasurer; and Giovanni Caforio, MD, President, U.S. Pharmaceuticals, Bristol-Myers Squibb Company, and Steven Romano, MD, Senior Vice President, Head, Medicines Development Group, Pfizer Inc, to serve on the executive committee.
About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.
|SOURCE National Pharmaceutical Council|
Copyright©2012 PR Newswire.
All rights reserved